The role of somatostatin analogs in the management of carcinoid tumors

J Endocrinol Invest. 2003;26(8 Suppl):79-81.

Authors

P Tomassetti¹, M Migliori, D Campana, E Brocchi, L Piscitelli, V Tomassetti, R Corinaldesi

Affiliation

¹ Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy. paola.tomassetti@unibo.it

PMID: 15233219

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents, Hormonal / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoid Tumor / drug therapy*
Gastrointestinal Neoplasms / drug therapy*
Humans
Immunologic Factors / administration & dosage
Interferon-alpha / administration & dosage
Lung Neoplasms / drug therapy*
Pancreatic Neoplasms / drug therapy
Quality of Life
Somatostatin / administration & dosage
Somatostatin / adverse effects
Somatostatin / analogs & derivatives*

Substances

Antineoplastic Agents, Hormonal
Immunologic Factors
Interferon-alpha
Somatostatin